Pharmacists' Group Calls for Regulation on Electronic Medicine Delivery
The President of the Pharmacists Syndicate, Zaid Al-Kilani, rejected the delivery of medicines through current electronic applications and platforms, confirming that providing such a service requires a comprehensive system to ensure medicine tracking, patient identification, and safe dispensing. He explained that medicines are subject to strict regulatory conditions, including inspection before reaching the market, proper storage, transportation, and delivery to the patient, and that medicines can only be sold through a pharmacist in a pharmacy. He pointed out that delivery necessitates an integrated tracking system that includes the patient's health record to enable electronic verification of prescriptions and medicines, especially since some medications are hazardous and could interact with others, which requires a pharmacist's medical consultation. Al-Kilani warned about unlicensed applications and online stores that deliver medicines, noting that these often lack proper conditions regarding the source of the medicines and the storage conditions during transportation. He emphasized that the General Food and Drug Administration enforces strict standards on transportation methods to ensure the quality and proper storage of medicines. He also mentioned that the remote delivery system used in some countries, such as the United States, has been halted due to the unavailability of essential requirements like proper tracking and health records. Al-Kilani reiterated that the syndicate supports advancements in healthcare services but only with guarantees for medicine safety and patient health. He called on organizations providing delivery services to obtain the necessary licenses and meet health tracking requirements. Previously, pharmacists and syndicate representatives emphasized the need to close unlicensed applications and hold responsible parties accountable, also advocating for the participation of the Pharmacists Syndicate president and experienced pharmacy representatives in committees responsible for developing remote health services.
Notice: This Is an AI-Generated Summary
Comments (0)